{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:34:20Z","timestamp":1777883660540,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100007865","name":"university of texas medical branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cure Addiction Now Foundation"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG3DA050317"],"award-info":[{"award-number":["UG3DA050317"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG3DA052282"],"award-info":[{"award-number":["UG3DA052282"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use: Research and Treatment"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The opioid overdose epidemic continues as a serious world problem, with postoperative opioid prescribing recognized as a critical contributor to opioid use disorder (OUD) development. Identifying risk factors associated with OUD in the perioperative setting is essential for developing targeted prevention strategies. This study aimed to evaluate the association of social determinants of health (SDoHs) and mental health conditions in predicting OUD within 1\u2009year following surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective cohort study used de-identified electronic health records from the TriNetX Research Network, evaluating over 295\u2009000 matched patients across individual risk factor cohorts. The index event was defined as the first opioid exposure within 3\u2009days after their first surgery. Patients with and without risk factors were propensity score matched and then odds ratios (ORs) and absolute risks were calculated for postoperative OUD within 1\u2009year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Significance at\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001 was present for all SDoHs assessed with individual ORs ranging from 0.77 (benzodiazepine use,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u20093\u2009026\u2009362) to 8.3 (homelessness, n\u2009=\u200916\u2009997). A cohort with known mixed risk factors showed an additive association with OUD risk. A validation cohort confirmed the methodology, showing no association between levothyroxine use and OUD development (OR 1.0,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.416, n\u2009=\u2009222\u2009471). The definition of OUD in this study was based on ICD-10 coding, which does not perfectly align with DSM-5 diagnostic criteria and may capture patients with persistent opioid use but without formal OUD diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Key SDoHs and mental health conditions significantly increase the risk of postoperative OUD. These findings underscore the need for preoperative risk stratification and targeted interventions, including multimodal analgesia and integrated mental health care to mitigate OUD risk in surgical populations. Addressing these factors is critical for advancing perioperative care and combating the opioid overdose crisis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/29768357261418824","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:28:28Z","timestamp":1776338908000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Socioeconomic and Psychiatric Factors with Postoperative Opioid Use Disorder: A Retrospective Cohort Analysis"],"prefix":"10.1177","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8516-2917","authenticated-orcid":false,"given":"Trevor L.","family":"Murphy","sequence":"first","affiliation":[{"name":"The John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Till","sequence":"additional","affiliation":[{"name":"The John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina R.","family":"Merritt","sequence":"additional","affiliation":[{"name":"Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Center for Addiction Sciences and Therapeutics, University of Texas Medical Branch, Galveston, TX, USA"},{"name":"Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4609-2767","authenticated-orcid":false,"given":"George","family":"Golovko","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.51821"},{"key":"e_1_3_3_3_2","unstructured":"U.S. Department of Justice Drug Enforcement Administration. Overdose deaths decline fentanyl threat looms. 2024. Accessed October 5 2024. https:\/\/www.dea.gov\/press-releases\/2024\/12\/16\/overdose-deaths-decline-fentanyl-threat-looms"},{"key":"e_1_3_3_4_2","unstructured":"U.S. Department of Justice Drug Enforcement Administration. Fake pills fact sheet. 2024. Accessed October 5 2024. https:\/\/www.dea.gov\/sites\/default\/files\/2024-11\/DEA-OPCK_FactSheet_November_2024.pdf"},{"key":"e_1_3_3_5_2","unstructured":"Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network: National Estimates From Drug-Related Emergency Department Visits 2024 (PEP25-07-005). SAMHSA; 2025."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S436898"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4552"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:122556"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jbcr\/irad045.037"},{"issue":"6","key":"e_1_3_3_10_2","first-page":"869","article-title":"Buprenorphine-naloxone for opioid use disorder: reduction in mortality and increased remission","volume":"25","author":"Paul KK","year":"2024","unstructured":"Paul KK, Frey CG, Troung S, et al. Buprenorphine-naloxone for opioid use disorder: reduction in mortality and increased remission. West J Emerg Med. 2024;25(6):869-874.","journal-title":"West J Emerg Med"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2023.09.013"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jbcr\/irac012.029"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.2686"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01080-8"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000001305"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2023.08.031"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnae120"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.021"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjb.2020.49"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-015-1025-2"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.2522\/ptj.20130597"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000326"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.893828"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.3298"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44220-023-00034-y"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1022863"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2020.03.045"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2020915"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0194"},{"issue":"3","key":"e_1_3_3_31_2","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch T","year":"2007","unstructured":"Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76(3):391-396.","journal-title":"Am Fam Physician"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/09638280903110079"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.4097\/kja.d.18.00217"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002094"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7490801"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/1558944720919936"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2017.07.009"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109337"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006332"},{"key":"e_1_3_3_40_2","article-title":"Effects of implementation and enforcement differences in prescription drug monitoring programs in 3 states: Connecticut, Kentucky, and Wisconsin","volume":"15","author":"Dickson-Gomez J","year":"2021","unstructured":"Dickson-Gomez J, Christenson E, Weeks M, et al. Effects of implementation and enforcement differences in prescription drug monitoring programs in 3 states: Connecticut, Kentucky, and Wisconsin. Subst Abuse Res Treat. 2021;15:1178221821992349.","journal-title":"Subst Abuse Res Treat"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11030437"}],"container-title":["Substance Use: Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768357261418824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29768357261418824","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29768357261418824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:53:37Z","timestamp":1777600417000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29768357261418824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":40,"alternative-id":["10.1177\/29768357261418824"],"URL":"https:\/\/doi.org\/10.1177\/29768357261418824","relation":{},"ISSN":["2976-8357","2976-8357"],"issn-type":[{"value":"2976-8357","type":"print"},{"value":"2976-8357","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"article-number":"29768357261418824"}}